A committee of the International Society for Stem Cell Research (ISSCR) did one heck of a document dump yesterday on stem cell policy, releasing a whole bunch of policy recommendations on stem cells and more. The torrent from ISSCR included a 37-page policy statement itself as well as several papers in top journals including the […]
ISSCR Releases Flood of Stem Cell Policy Docs Read More »
It’s been a great couple days so far here at the World Stem Cell Summit in Atlanta. You can follow it on Twitter using the #WSCS15 hash tag. I first attended it 5 years ago in Pasadena. One of the special aspects of WSCS is it brings together diverse stakeholders in a way that just
World Stem Cell Summit 2015: IPS cells, #CRISPR, CAR-T Read More »
Who might make a fantastic new CIRM President? The California stem cell community is abuzz with this question. This new President will not only lead CIRM today, but also in all likelihood will steer CIRM in its new incarnation after 2017, what I’ve called CIRM 2.0. At least that would be ideal. CIRM has posted a
Dozen Candidates To Be New CIRM President Read More »
The World Alliance Forum held a really great meeting yesterday in SF about the future of stem cells. Below, Johnathon Anderson has a great guest post summarizing the meeting. The collective brain power in the room was pretty staggering. The meeting brought together stem cell leaders from academia, industry, startup incubators and funding agencies. The purpose
Guest Post on the Future of Stem Cells: World Alliance Forum Meeting Read More »
If there was one stem cell meeting I would absolutely not want to miss next month in November if at all possible, it is the 2013 World Alliance Forum “Future of Stem Cells” in San Francisco. Are you going? Win free tickets to this meeting here! Unfortunately I have a conflict so I will this
World Alliance Forum “Future of Stem Cells” features Shinya Yamanaka Read More »
Update in 2020: It seems now after all these years that the consensus in the now more mature field is that IPSCs and ESCs are nearly identical in most cases, and both have some of the same translational challenges such as teratoma-forming activity. It’s interesting to read this post from nearly 10 years ago and
iPS cells coming into focus: not quite so similar to ESC after all Read More »
What do a Panama stem cell clinic and the Duke Autism Center have in common? More than I might have imagined. It’s a remarkable story that needs telling. Duke Autism Center There is a puzzle when it comes to the controversial idea of using cord blood for autism. Why? Because two of the strongest proponents
Duke Autism Center has Panama clinic to thank for $10s millions? Read More »